Tag: Covaxin

COVID-19 Vaccination Drive On R-Day: Only 5K Beneficiaries Get Jabs Across Country, Count Reaches 20 Lakh
COVID-19 Vaccination Drive On R-Day: Only 5K Beneficiaries Get Jabs Across Country, Count Reaches 20 Lakh

New Delhi: On the 11th day of the COVID-19 vaccination drive on Tuesday, only 5,615 healthcare and frontline workers were given the coronavirus vaccine. With this, the tally of those vaccinated across the country reached to over 20 lakh on Republic Day. As per the provisional report, 5,615 beneficiaries were vaccinated in five states – […]

  • Tuesday, 06 April 2021
Bharat Biotech
Covaxin Neutralizes UK COVID-19 Variant: Study

Hyderabad: Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study. According to the research paper carried by bioRxiv, the preprint server for biology, the study has dispelled the uncertainty of possible neutralization escape. A group of researchers from Indian Council […]

  • Tuesday, 06 April 2021
COVID Resurgence
Odisha Deputes 36 Doctors To 4 Districts For Smooth COVID Management

Bhubaneswar: Alarmed by resurgence of COVID-19 cases, the Odisha government on Monday appointed 36 doctors for smooth management of COVID19 related work in four districts. As per as notification by…

  • Monday, 05 April 2021
COVID-19 Vaccination Drive: 3rd Phase To Begin In March, Will Cover Those Above 50
COVID-19 Vaccination Drive: 3rd Phase To Begin In March, Will Cover Those Above 50

New Delhi: The most vulnerable age group of people in the country, those aged above 50 will get the first jab in March second week onwards, Union Health Minister Harsh Vardhan informed Parliament on Friday. The Health Minister said since the drive for the second phase to cover over 2 crore frontline workers is under […]

  • Monday, 05 April 2021
Covaxin Effective For 9-12 Months, No Serious Side-Effects So Far: AIIMS
Covaxin Effective For 9-12 Months, No Serious Side-Effects So Far: AIIMS

New Delhi: Mathematical calculations indicate that Covaxin may provide immunity against Covid-19 for 9 to 12 months, and there may be a booster shot after this period elapses, Y.K. Gupta, the President of AIIMS Bhopal and Jammu, told IANS. Stressing on the safety and effectiveness of Covaxin, Gupta, former Dean (Academics), and ex-Head, Department of […]

  • Monday, 05 April 2021
COVAXIN
AIIMS: Covaxin Effective For 9-12 Months, No Serious Side-Effects So Far

By Sumit Saxena New Delhi: Mathematical calculations indicate that Covaxin may provide immunity against Covid-19 for 9 to 12 months, and there may be a booster shot after this period elapses, Y.K. Gupta, the President of AIIMS Bhopal and Jammu, told IANS. Stressing on the safety and effectiveness of Covaxin, Gupta, former Dean (Academics), and […]

  • Monday, 05 April 2021
ovaxin-2nd-dose-received
NITI Aayog Member Receives 2nd Dose Of Covaxin At AIIMS

New Delhi: NITI Aayog member (health) Dr VK Paul on Tuesday received the second dose of Covaxin to protect him against coronavirus at the All India Institute of Medical Sciences (AIIMS) here. Paul, also head of the National Task Force on Covid-19, has not reported any major side effects after the first jab over a […]

  • Monday, 05 April 2021
Naveen takes vaccine
Odisha: CM Naveen Takes Covid-19 Jab As Govt Orders Offline Registration For Vaccination

Bhubaneswar: Chief Minister Naveen Patnaik on Monday tackled the vaccine hesitancy by taking the first dose Covid-19 jab at the Odisha Assembly dispensary even as the the government ordered off-line registration of the beneficiaries during the second phase inoculation drive, beginning today. Patnaik was administered the home grown Covaxin developed by Bharat Botech and Indian […]

  • Sunday, 04 April 2021
Bharat Biotech
Covaxin Demonstrates Interim Clinical Efficacy Of 81%

Hyderabad: Bharat Biotech on Wednesday announced the first interim analysis of Covaxin, which shows the efficacy of the Covid-19 vaccine to be at 81 per cent. The Hyderabad-based vaccine maker said whole virion inactivated Covid-19 vaccine candidate demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved […]

  • Sunday, 04 April 2021
Bharat Biotech
Covaxin Has No Serious Side Effects, Says Lancet

Hyderabad: Covaxin, India’s first indigenous vaccine for Covid-19, is “safe, immunogenic with no serious side effects”, says leading medical journal The Lancet in its interim efficacy analysis. The Lancet – Infectious Diseases Journal, published phase 2 results of the vaccine developed by Hyderabad-based Bharat Biotech. However, the report made it clear that efficacy cannot be […]

  • Sunday, 04 April 2021
India Studies Post-Vaccination Adverse Events Amid Concerns Over Covishield
India Studies Post-Vaccination Adverse Events Amid Concerns Over Covishield

New Delhi: Amid concerns over dangerous side-effects of the Oxford’s COVID-19 vaccine, India is evaluating all serious adverse events post-vaccination to determine the causality aspects of Covishield and Covaxin, an expert associated with the process said Saturday. His comments came in the backdrop of some European countries suspending the Oxford-AstraZeneca COVID-19 vaccine Covishield over fears […]

  • Saturday, 03 April 2021
COVID-19 Vaccine: Govt Places New Purchase Order For 10 Crore Doses Of Covishield
Interval Between Doses Of Covishield Extended To 4-8 Weeks

New Delhi: India has decided to extend the interval between doses of Covishield vaccines from four to eight to four to eight weeks, the Health Ministry said on Monday. The Ministry said that protection is enhanced if the second dose of Covishield is administered between 6-8 weeks, but not later than stipulated period of 8 […]

  • Friday, 02 April 2021
Bijaya Panigrahi
Odisha Targets 1 Cr Total Vaccinations, 1.5 Lakh Per Day, Says Health Director

Bhubaneswar: With a resurgence in COVID cases across India, Odisha Health Department Director on Friday informed that the State has targeted to vaccinate a minimum of 1 Crore people, around 25% of the total population. Speaking to the media, Bijay Panigrahi, the Director of Odisha Health Department said that the State has already registered 20.95 […]

  • Thursday, 01 April 2021
scrollToTop